#ivf cost in korea

[metatechinsights]

Fertility Tourism Market Size & Forecast 2025-2035

Industry Outlook

The Fertility Tourism market accounted for USD 0.92 Billion in 2024 and is expected to reach USD 17.5 Billion by 2035, growing at a CAGR of around 30.8% between 2025 and 2035. Fertility tourism refers to the process by which people travel to another country to seek treatments for infertility, which include IVF, egg/sperm donation, or surrogacy. They include low charges, legal requirements, or the existence of better treatment alternatives in the patient’s home country. Some patients prefer fertility tourism to get better success stories, technology, or procedures that are banned in the country. Frequently visited countries are those that boast a stable healthcare system and permissive legislation on reproductive services.

Report Scope:

2024

2035Market Size in 2024 & 203520.0015.0010.005.000.0020242035ParameterDetailsLargest MarketNorth AmericaFastest Growing MarketAsia PacificBase Year2024Market Size in 2024USD 0.92 BillionCAGR (2025-2035)30.8%Forecast Years2025-2035Historical Data2018-2024Market Size in 2035USD 17.5 BillionCountries CoveredU.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Switzerland, Sweden, Finland, Netherlands, Poland, Russia, China, India, Australia, Japan, South Korea, Singapore, Indonesia, Malaysia, Philippines, Brazil, Argentina, GCC Countries, and South AfricaWhat We CoverMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and over 10 companiesSegments CoveredType of Treatment, Service Type, Gender, Age Group, Provider Type, and Region

To explore in-depth analysis in this report - Request Free Sample Report

Market Dynamics

Access to advanced reproductive technologies attracts international patients seeking treatments.

Several factors give rise to fertility tourism among patients, including the high cost of treatment in the patient's home country, readily available advanced techniques, and freedom in legal measures on ARTs of different countries. Almost every patient wants to find a place where new methods of treatment or technologies, such as preimplantation genetic testing or freezing of eggs, are used at affordable prices. Besides, several countries permit ART and surrogacy, and egg donation draws patients from other countries seeking personalized treatment, onsite care, and niche services.

It was estimated by the American Society for Reproductive Medicine that about 7.4 million women in the United States are infertile, placing them in a situation to seek services in other countries, especially where the service is inadequate or too costly. It further supports our belief in the increased need for extended fertility services within the international healthcare market.

Lack of insurance coverage increases out-of-pocket costs for patients.

The Fertility Tourism market embodies several limitations related to fiscal and governance constraints. There is still no insurance coverage for fertility treatments, most patients have to incur out-of-pocket expenses. This may discourage anyone who would wish to travel to other countries for treatment because the financial burden can be overwhelming. Furthermore, it is proven that even in different countries, the rules might be different, and this may cause contraindications for patients. That includes various standards of their treatment, the legal aspects of used treatments, and possible difficulties in further treatment.

Other factors likely to discourage would-be patients include distrust over the quality and safety of the facilities in other countries. However, cultural and ethical factors may play a role in the decision-making process. Therefore, people may refrain from traveling to seek other procedures they deem ‘unethical’ or are publicly acceptable by society. All these factors make the decision-making process very complicated by influencing the general growth of the Fertility Tourism Market.

Growing Research and development leads to new fertility treatment options

Fertility Tourism Market has emerged because of the rising need for assisted reproductive technologies, regulations, prices, and accessibility in different countries. Couples looking for better treatments or cheaper ways of having the baby, through IVF, egg donation, or surrogacy, among other services, move around and seek state-of-the-art equipment and services. Spain, Greece, India, and Thailand now benefit from their well-developed medical tourism sectors since they provide global-class fertility services. Fertility tourism itself offers destinations a means to develop their healthcare industries, attract global consumers, and create substantial revenue while offering patients fewer waits and more choices. However, there are issues of ethics, the law, and the safety of patients, which are always probed as this market develops.

Industry Experts Opinion

 “As the field of fertility medicine expands, so does Inception, and through effective marketing and communication strategies, we can deliver key educational messages and introduce new products and service line offerings that will enhance the fertility journey for every aspiring parent,"

TJ Farnsworth, CEO and Founder of Inception.

“Infertility is an emotionally charged experience for any couple. During a consumer research we had conducted, we found that nearly 2 in 3 couples undergoing treatment found it extremely challenging, and over 90% couples lacked the financial support for the same. We noted an emerging sentiment of insurance coverage, especially among the Tier-2 population, where the spending capacity on healthcare delivery is extremely limited. This proposition is a unique and first-of-its-kind to be offered to couples,”

Vikas Anand, CEO of SafeTree Insurance said in a statement.

Segment Analysis

Based on the type of treatment, the Fertility Tourism market is classified into In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Artificial Insemination, Egg, Donation and Surrogacy, Preimplantation Genetic Diagnosis (PGD), and Others. In Vitro Fertilization (IVF) is the dominant type of treatment in the Fertility Tourism Market because many people prefer this method. This treatment is preferred by many due to its efficiency and the level of technology used, and it can deal with most causes of infertility. The treatment is generally less costly in some countries and is one of the core motivators of medical tourism. IVF also presents combined methods such as egg/sperm donation and Preimplantation Genetic Diagnosis (PGD), making the procedure attractive for international clients who need reproductive help.

You can also buy individual sections of this report.

Would you like to review the price list for each section?

Request Sectional Data

[helthcareheven]

Discovering Healing Havens: A Guide to Medical Tourism

Reasons for Seeking Medical Care Abroad

One of the primary factors driving the growth of surgical tourism is the high cost of healthcare in developed countries. For many elective and non-emergency procedures, the costs in the United States, Canada, United Kingdom and other Western nations have become prohibitively expensive for average citizens and even those with health insurance. Medical tourists are able to travel abroad and receive treatments at a fraction of the price they would pay at home. In many destination countries, the overall package of medical care, travel, lodging and other ancillary costs is 30-90% cheaper than equivalent treatment in a developed country.

Another motivation is shorter wait times. In countries with universal healthcare systems, there can be lengthy waits for non-emergency surgeries and procedures. The average wait time for a hip replacement in Canada is over 6 months, while knee replacements in the UK have 18-month waits. By traveling abroad, medical tourists are able to get treated more quickly without delay. India, Thailand and other popular destinations generally have minimal to no wait times.

Medical Specialties and Treatments Sought

While originally centered around dental care and cosmetic surgeries, medical tourism has expanded to cover a wide range of specialties and treatments. Some of the most common include:

- Cardiology - Angioplasty, angiography, bypass surgery and stent placement are popular cardiological procedures sought by medical tourists.

- Orthopedics - Knee replacement, hip replacement, spinal surgery and arthroscopic procedures feature prominently. The use of robotics and computer navigation systems allows for less invasive techniques.

- Dentistry - Dental crowns, veneers, dental implants and oral surgery make up a major portion of surgical tourism, especially to Thailand, Hungary and Mexico.

- Fertility Treatment - In vitro fertilization (IVF) costs a fraction abroad versus in the Western world. Countries like India, Thailand and Cyprus attract fertility tourists.

- Cosmetic Surgery - Tummy tucks, breast augmentations, face lifts and other aesthetic procedures drive traffic to countries such as Thailand, South Korea and Costa Rica.

- Ophthalmology - Cataract removal and lens replacement surgeries are commonly sought abroad alongside refractive procedures like LASIK eye surgery.

Popular Medical Tourist Destinations

Certain countries have built strong reputations as top destinations in medical tourism. Some of the leaders are:

India - Advanced facilities, JCI-accredited hospitals, large pool of English-speaking doctors and very low costs have made India the world's fastest growing market. The Indian healthcare sector earns over $3 billion yearly from medical tourists.

Thailand - Known especially for quality dental and cosmetic work at bargain prices. Thais are perceived as being quite skillful with bedside manner. Hospitals meet international standards.

Singapore - Highly developed medical infrastructure, including the promotion of integrated surgical tourism clusters with hotels. Singapore attracts Asian patients as well as those from the West.

Malaysia - Healthcare quality equals that of Western countries at half the cost or less. Malaysia Medical Council regulates facilities, and English is widely spoken in the healthcare industry.

Mexico - Popular for procedures like dental work, bariatric surgery, and eye/laser corrective surgeries due to competitive pricing. Many accredited JCI hospitals near the US border.

Challenges and Risks of Medical Tourism

While surgical tourism provides considerable benefits, certain risks and challenges exist that need to be considered. Post-surgical complications may arise, and standards of aftercare can vary in different countries. The legal recourse and patient rights available may not equal what patients expect at home. Medical records and follow-ups may be difficult between multiple healthcare systems. Travel itself poses some health threats like the transmission of new infections or bacterial strains. Cultural differences, language barriers or unfamiliar practices can affect the levels of comfort experienced abroad. Medical tourists need to carefully vet facilities and providers through organizations that accredit and certify hospitals overseas. With prudence, most risks can be minimized to allow patients to reap the rewards of affordable, timely medical care in internationally accredited centers worldwide.

Growth Outlook

The global medical tourism industry was estimated to be worth around $10-40 billion worldwide as per different surveys. Advanced Asia-Pacific destinations capture approximately 45-65% market share of the entire pie while the remainder is split between Latin America, Eastern Europe, Middle East, Africa and other regions. India alone serves an estimated 150,000-200,000 medical tourists every year currently. Going forward, the worldwide numbers are forecasted to grow substantially in the coming years. Driven by factors like the shrinking value of most foreign currencies against the USD, an expanding medical infrastructure abroad, more trade agreements lowering travel barriers, and persistent high healthcare costs domestically – surgical tourism is emerging as a multi-billion dollar industry worldwide with potential for further significant increase in the future if present trends continue.

[meghanester]

Fertility Test Market 2023-2035 CAGR, SWOT Analysis, Factors Driving the Market Growth.

Research Nester released a report titled “Fertility Test Market: Global Demand Analysis & Opportunity Outlook 2035” which delivers detailed overview of the global fertility test market in terms of market segmentation by product, mode of purchase, end-user and region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global fertility test market is estimated to grow with a moderate CAGR during the forecast period, i.e., 2023-2035. Market growth can be attributed to the increase in the average age of first-time pregnancies across the globe owing to the decrease in first births among teenage women and the rise of first births among women aged over 30 years. OECD Family Database stated that the mean age of first-time pregnancy has increased from 29 to 30 globally by 2019. The declining fertility rate in women and men, along with the rise in the prevalence of disorders, such as, PCOS and obesity, are estimated to promote the market growth. Growing fertility education and the easy availability of fertility monitors through e-commerce websites, pharmacies, and retail shops and drugstores also contribute to the market growth.

Download Sample of This Strategic Report: https://www.researchnester.com/sample-request-3231

The global fertility test market is segmented by product into ovulation prediction kits and fertility monitors. The ovulation prediction kits segment is estimated to hold the highest share owing to advantages, such as, low cost, rising use of ovulation prediction kits, easy availability, and higher accuracy. On the basis end-users, the fertility test market has been segmented into home care settings, hospitals, and fertility clinics. Among these, the home care segment is projected to hold the highest share in the market. The growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy accessibility of fertility and ovulation monitors on e-commerce websites, rise availability of easy-to-handle devices, and the growing preference for the confidentiality of test results.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market in the Asia Pacific is predicted to grow at the highest CAGR over the forecast period owing to the large population, especially the large young population which falls under the fertility age bracket. Moreover, increasing investment in healthcare infrastructure by government and non-government organization, along with rising awareness regarding sexual health and fertility are estimated to further boost the market growth. Moreover, less competition among players and friendly regulatory policies in developing markets have encouraged companies to focus on emerging countries.

Request for customization @ https://www.researchnester.com/customized-reports-3231

Declining Fertility Rate among Men and Women to Drive Market Growth

According to the CDC data from 2020, US births have been down since 2007, and total fertility rates have similarly declined. Total fertility rates and general fertility rates have both dropped by 4% during 2019, reaching record lows.

Rise in lifestyle disorders among men and women leads to rise in the occurrences of couples opting for IVF or surrogacy which are the major factors growing the fertility testing market. In Japan South Korea, and Singapore, due to low birth rate governments are offering subsidizes in the cost of infertility treatments. However, low precision of test results of fertility test kit and high cost of kit to restrain market growth in the near future.

Access Our Report at: https://www.researchnester.com/reports/fertility-test-market/3231

This report also provides the existing competitive scenario of some of the key players of the global fertility test market which includes company profiling of Swiss Precision Diagnostics, Legacy, Inc., Dadi Inc., Everlywell, Inc., Fertility Focus, ExSeed Health, Geratherm Medical, VirtualExpo, AdvaCare Pharma, and Valley Electronics AG. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global fertility test market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

About Us

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[coochiequeens]

More than one million employees of Amazon will now have access to a variety of family-building benefits after the e-commerce giant expanded the perks to staff around the world.

Employees will have free virtual access to board-certified OB-GYNs, reproductive endocrinologists (fertility doctors), coaches, and other care providers to support fertility.

They will also receive support for preconception, egg freezing, intrauterine insemination, in vitro fertilization, adoption, and surrogacy.

"Our benefits are designed to care for all our employees' needs, and that means ensuring they have the resources they need to live their best lives, regardless of their personal circumstances," said Lian Neeman, global director of benefits at Amazon, in a media release.

Who is eligible for the benefits?

Eligible employees include full time, part time, and hourly, as well as their partners, from 50 countries around the world including:

Asia-Pacific: Australia, India, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam

Europe: Austria, Belgium, Croatia, Czech Republic, Denmark, Estonia, Finland, Greece, Iceland, Norway, Poland, Portugal, Republic of Serbia, Romania, Slovakia, Spain, Sweden, Switzerland, United Kingdom

Latin America: Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru

Middle East and Africa: Bahrain, Egypt, Israel, Jordan, Kenya, Kuwait, Mauritius, Morocco, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates

The benefits will be provided through Maven Clinic, with its care advocates to guide Amazon employees in family building and providing referrals to high-quality clinics and agencies.

"Maven is an employee-friendly benefit that takes the guesswork out of the family-building process, which can often be confusing and overwhelming," Neeman said. "Maven's approach to fertility and family-building supports our employees around the world and is tailored to each person."

Kate Ryder, founder and CEO of Maven Clinic, said they are delighted to support Amazon employees around the world in planning and growing their families.

"There are too many barriers to care in healthcare systems that were not built around the needs of women and families, and Amazon is cutting through that complexity by making it exceptionally easy for their employees to access high-quality, personalized care in their own language at any hour of the day or night," Ryder said in a media release.

Amazon's family-building benefits started in the United States in 2019 before they were expanded early this year to Canada.

The e-commerce giant now joins other organisations such as Goldman Sachs and JP Morgan that are extending fertility benefits to employees.

🤨 I know an Amazon worker who was injured on the job, a head injury. Instead of sending him home to see an outside doctor they had him see their in house doctor. He was declared fine but days later he still hasheadaches. The same company is going to give fertility benefits?

Shouldn't a health care site list their health benefits first then talk about their cost effectiveness?

[stray3racha]

21 Questions!

Wow! Haven’t been tagged in so long! Thank you for tagging me @cottonchandy 💖

Name: Michaela

Nickname: Kayla, or bunny on here 🥰

Gender: Female

Star Sign: Aquarius ♒️

Height: 5’6 ? 5’7?

Current time: 9:38pm !

Favorite Artists: Stray Kids, BAP, SHINee, iKON, SF9, Ateez, WayV, Monsta X, NCT, Seventeen, Childish Gambino, Got7, Block B, Rich Brian, i could go on and on lmao

Song stuck in my head: mmm Bakugo! by Kamil 😂

Last movie I saw: I recently watched Blackkklansman finally. I loved it

Last thing I googled: “cryobank iui ivf cost”

Other blogs: most are private. i do have st-ay-tiny

Do I get asks: yes, but I’m really bad at checking them haha

Reason of your url: i love stray kids. and 3RACHA songs had a huge impact on me. stray3racha. Lmao.

Following: i follow a ton since this is my main. I’d say like 400? 500? Or more.

Average sleep: uh. 2 hours at a time if I get more it’s a miracle. I have insomnia & chronic fatigue so it’s a battle.

Lucky number: I’ve always said 7 or 3. Lately, I’ve heard it’s 4 by the birthday method.

Currently wearing: red polo, black jeggings; my work uniform haha.

Dream job: Translator ideally.

Dream Trip: South Korea 🤩 Maybe New York again or LA again 🥰

Favorite foods: Bugolgi! It’s the best! And I love all soup lmao.

Instruments: I used to play clarinet in middle school. Other than that, I suck.

Favorite Song: Stray Kids - Insomnia & BAP - Blind.

Tagging {only if you feel like it!}: @changbeanie @hyyunjinn @untalkativedreamer @nctmoonstarsun and anyone else who wants to do a simple cute game!

[thelauracelestettcjourney]

Sperm Allergy?!

Yup. You read that right. Sperm allergy. 

I was finally able to go to a new doctor about a month ago. My new doctor is a wonderful woman who actually to time to listen to my concerns, took time to help me find the best possible route to a solution, and all I took was one visit to get my referral to a gyno. Which to me was a “About fucking time!” moment. With the referral she told me that she also suspected I had a sperm allergy.

Now you guys are probably like “the fuck is a sperm allergy?” Well in short I am allergic to my husband’s sperm.

It all started after we go married back in 2015. It was our wedding night and it was our first time together. Not just our first time as a couple making love, nope. It was our FIRST time having sex. At all. That night itself was amazing. Until he finished inside. Then the pain started and I don’t mean like “ we’ve been going at it for a while my vag is sore let’s take a break” pain. I mean PAIN like having a sun burn with 10 paper cuts in the same area, poor lemon juice on it, pour alcohol on it, poor salt on it, and slap it kind of pain. well more like my vag was being set on fire from the inside is what it felt like. However I thought, “Well this is my first time. I know it hurts and the sperm is probably messing with my ph levels. no biggie” but boy did it hurt and I cried for hours hoping the paid would just disappear. But not long after our wedding, my husband was shipped off to S. Korea. (For those wondering he is in the U.S. Army) He was gone for a year. When he came back and we had sex again...same thing. The moment he finished it felt like my vagina had been set on fire. Again I thought, “It’s the first time we have sex since we got married and it’s been a while so it’s just that.” But boy did it hurt so bad. I couldn’t sit, stand, lay down. walk. anything. 

Soon after he got back we moved to Texas. And that’s when I really noticed that it was EVERY time we had sex it hurt. Not to the same extent but non of the less there was some sort of pain or discomfort. When I was finally able to go to my first doctor I told her about it . She tested me for STDs, vagintis, bacterial vaginosis, and yeast infection. That first visit established it was bacterial vaginosis. So I’m like “Oh okay, that makes sense.” So she gave me my meds for it, and that was that. A couple months later I was back again. Why? I was still having pain as soon as my husband would finish inside. She does the same test, and again bacterial vaginosis. At this point I was like “That is twice in less than 3 months. What up?” She just said it’s because sperm can though the ph of the vagina off, and that is what triggers it. This goes on for a full year before I’m like...”something is off. This isn’t right.” So here we go again to the doctor. This time become more insistent on figuring out what is wrong. She just says it’s an infection, here are some meds, come back if the infection returns. I ask for a referral to a gyno, her response is “I can’t refer you to a gyno unless your papsmear show’s something abnormal.” At this point it’s been like 2 years. So I was like Fuck this I’m out. Gonna find a new doctor who will listen to me and take me seriously.

In the time it took me to find a good doctor, when i’d get sick (rather than wait a month to get seen by my docotor) I’d go to urgent cares. 

And now here is where it all changed with my  new doctor. I went in for my first visit with her, and she took me seriously and gave me my referral. 

The gyno we went to took me seriously as well, and here’s the thing about sperm allergies, they all vary in severity as well as it’ s already rare as it is. I was my gyno’s first case of sperm allergy. He sent me to an allergist to confirm the sperm allergy. 

My appointment with the allergist was yesterday. We are now waiting on lab results for it. However he also did say that it is hard to confirm a sperm allergy because there is really no good way to test for it. As well as starting to discus treatment options. Non of which are fun. I basically have two choices. Get used it or deal with it.  And it sucks especially when you are trying to have kids but are allergic to the one thing you need to have babies. At this point it feels like my only two options for a biological child are IVF or artificial insemination. Which of course cost a lot of $$$$$ which we don’t have. And I don’t know what to do. All I want to do is cry.  

[nikhilghodse20051994]

Global IVF Services Market Research, Size, Witness Stunning Growth By 2028 | The Insight Partners

According to The Insight Partners market research study titled “IVF Services Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Cycle Type and End User,” the market is expected to reach US$ 31,613.76 million by 2027 from US$ 13,496.29 million in 2019. It is estimated to grow at a CAGR of 11.6% from 2020 to 2027. The report highlights the trends prevalent in the market and the factors driving the market along with those that act as deterrents to its growth.

The growth of the global IVF services market is driven by the increasing incidence of infertility, rising number of fertility clinics and infertility services with government support, and growing number of products launches and developments. However, the high procedural cost of reproductive techniques and risks associated with infertility treatment hinder the market growth.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis –

A few prominent players operating in IVF Services market are Max Healthcare; Bloom IVF; CCRM Fertility.; OXFORD FERTILITY; Create Health (Create Fertility); Medicover; Aevitas Fertility Clinic; BIOART Fertility Clinic; Prelude Fertility, Inc.; and Gift ov life. The companies have maximized their growth with several inorganic strategies to enhance the market value and maintain position in the market. For instance, in March 2019,Prelude Fertility announced a partnership with Inception Fertility. The partnership made Prelude the largest fertility services provider in the US and added Aspire Fertility clinics to the Prelude Network.

In terms of cycle type, the IVF services market is segmented into mobile devices, mobile applications, and enterprise mobility platforms. The fresh IVF cycles segment held the largest market share in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period. Fresh IVF cycles is a shorter process to conceive pregnancy (if the procedure is successful). This advantage of fresh IVF cycles is likely to have a positive impact on the adoption of the procedures, device, and the service sectors.In addition,owing to the high success rate of the procedure in the first attempt, it can be performed even in complicated cases. Thus, the IVF services market for the fresh IVF cycles segment is likely to witness the fastest growth in the coming years.

Click here to avail lucrative discounts on our latest reports. We offer student, enterprise, and special periodic discounts to our clientele. Please fill the inquiry form below to know more -

The report segments the global IVF services market as follows:

By Cycle Type

Fresh IVF Cycles

Thawed IVF Cycles

Donor Egg IVF Cycles

By End User

Fertility Clinics

Hospitals

Surgical Centers and Clinical Research Institutes

By Geography

North America

US

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific (APAC)

Japan

China

India

Australia

South Korea

Rest of APAC

Middle East & Africa (MEA)

South Africa

UAE

Saudi Arabia

Rest of MEA

South and Central America (SCAM)

Brazil

Argentina

Rest of SCAM

Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods –

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

[identybeautynet]

Baby bust : Can policymakers boost dwindling world fertility rates?

Baby bust : Can policymakers boost dwindling world fertility rates? When Choi Yoon-seo became pregnant in 2020, South Korea paid her $500 — a reward for helping the country address its dire demographic crunch. That year it hit its lowest fertility rate on record at 0.84 children per woman — the lowest in the world. The government in Seoul has since increased the one-off pregnancy gift to around $1,700. But Choi said the idea that the payments would encourage her to have another baby was laughable. “I used up the whole amount on prenatal tests before the halfway point of my pregnancy,” she said. Since her son was born in January 2021, the 40-year-old has struggled with family, societal and economic pressures. She had to give up her job as a social worker and became overwhelmed with “so much guilt over not being able to be a good mother”. The state’s childcare subsidies are “unrealistic” given the cost of living and education in the Korean capital, she said. Seoul’s efforts are not unusual. Developed economies are offering increasing amounts in subsidies to encourage citizens to have more children. But there is little evidence that they are having an effect: fertility rates are falling rapidly across the rich world. “Pronatalist policies haven’t really been shown to consistently change fertility levels,” said Bernice Kuang, a demographer at the University of Southampton, in the UK. You are seeing a snapshot of an interactive graphic. This is most likely due to being offline or JavaScript being disabled in your browser. France was one of the first countries to pioneer such policies. It first introduced financial support for families with three children or more in the 1980s and then upped it to cover those with two children or more from 1994. Allowances have also been given to parents who choose to stop working in order to raise a child and tax credits offered for childcare. More recently, other European countries have followed France’s lead. In 2020, Hungary designated fertility clinics a “strategic” sector and made IVF treatment available for all women. And last year the Italian government introduced incentives aimed at reversing demographic decline which included longer parental leave for fathers. “An Italy without children is . . . destined to slowly grow old and disappear,” prime minister Mario Draghi warned.   Baby Bust : The Demographic Crunch Global birth rates are falling and the world’s population will begin to contract in the coming decades. The FT examines why — and whether policymakers can do anything about it. Day 1: How the pandemic affected the baby bust Day 2: China is at the centre of global population crunch Day 3: Can policymakers do anything about it? Day 4: Learning to live with the economic consequences   Despite this, European fertility rates are still falling. In France, the rate has dropped from above two children per woman in 2010 to 1.83 in 2021, according to data from the country’s statistics office Insee. A recent bill put forward by politicians from the Republicans party blamed cuts to family support by successive presidents François Hollande and Emmanuel Macron. As evidence in favour of subsidies, demographers cite surveys indicating that couples in some countries are not having as many children as they would like; generally women would like to have around two children, above the actual birth rate in many countries. You are seeing a snapshot of an interactive graphic. This is most likely due to being offline or JavaScript being disabled in your browser. “Low fertility is not because women don’t want kids, but because having kids has become too difficult or costly,” said Lyman Stone, adviser at the consulting firm Demographic Intelligence. Kuang said that lower-income couples needed “financial support and affordable childcare” while higher income couples “need policies which make it easier for working people to balance childcare and, say, school pick-up, with their jobs”. But Kuang cited South Korea’s situation as evidence that other factors were also at play, “such as rigid gender norms and the unequal division of labour within the household”. “Governments want to make it so that women can do childcare as well as work, but some women don’t want to work that hard and some families don’t want to operate that way,” said Kuang. “Can you make it so that men can do more? Like find a way for them to work all day and take care of their kids.” Tomas Sobotka, who leads a research group in comparative European demography at the Vienna Institute of Demography, said there was some evidence that greater gender equality could help. High-income countries with higher fertility — such as Norway, Sweden, Iceland, France, and Belgium — also score highly on different aspects of gender equality. “Higher equality allows especially better-educated women an easier combination of career and family life,” Sobotka said. “Why not allow some of the men to retreat from work for two or three years to take parental leave and then head back to work?” But even so, he questioned whether governments should be trying to intervene in such personal choices. “Governments shouldn’t be making explicit incentives to get women to have more babies than they wish just to fulfil some national quota or their desire to create a small baby boom,” he said. Source link Read the full article

[newsmartmarketing]

In-Vitro Diagnostics and Cell Culture Medias Market 2022 | Industry Size, Share, Demand And Growth Analysis Report Till 2028

The study on In-Vitro Diagnostics and Cell Culture Medias Market with its type and application sales analysis is very essential for all the decision-makers or strategists operating in this industry. The report is made by analysts with deep industry knowledge and experience. The global, regional, and country annual sales and revenue has been studied for the historical years and estimated for the current year. With the help of analytical tools, primary interviews, and data triangulation the report is enriched with quality data. The qualitative data on the upcoming industry trends with market triggers and risks are covered as a separate section in this comprehensive report.

As understood and analyzed in the global In-Vitro Diagnostics and Cell Culture Medias market report the growth CAGR in the year 2022 to 2028 is showing a promising inclination. The macro and microeconomic conditions are studied and forecast data is anticipated.

Click here to get a FREE Sample PDF Copy of the In-Vitro Diagnostics and Cell Culture Medias Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-59116

As per this report analysis, the In-Vitro Diagnostics and Cell Culture Medias market is expected to show a CAGR (revenue) of xx% between the forecast years and the global market size can cross USD XX million by the end of 2028, growing from USD XX million in the year 2022. This report specifically covers the global market share (sales as well as revenue) of key companies in the In-Vitro Diagnostics and Cell Culture Medias business, as mentioned in a separate Chapter 3.

Regionally, the In-Vitro Diagnostics and Cell Culture Medias market data is studied under the below-mentioned regions and countries – Americas covering (United States, Canada, Mexico, Brazil), APAC covering (China, Japan, Korea, Southeast Asia, India, Australia), Europe covering (Germany, France, UK, Italy, Russia, Spain), Middle East & Africa covering (Egypt, South Africa, Israel, Turkey, and other GCC Countries).

This research study gives a comprehensive overview of market share and growth opportunities of the In-Vitro Diagnostics and Cell Culture Medias market as per type and application. The report also covers key manufacturers’ profiles with sales and gross margin data.

The key manufacturers covered in this report: Breakdown data in Chapter 3.

FUJIFILM Irvine Scientific

Nidacon International AB

Genea Biomedx

FertiPro

Kitazato Corporation

Vitrolife AB

Microm Ltd

City Fertility

Corning Incorporated

Gynemed

Others

To inquire about report customization, feel free to reach out to our team of expert analysts @ https://www.decisiondatabases.com/contact/ask-questions-59116

This study considers the In-Vitro Diagnostics and Cell Culture Medias value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 11.7.

Reagent

Medium

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 11.8.

Hospital

IVF Research Center

Others

The latest developments of the industry and the sales channel, manufacturing process along with the manufacturing cost study is covered in the report.

Key Questions Answered –

What will be the In-Vitro Diagnostics and Cell Culture Medias market CAGR and size between 2022-2028?

Who are the top/leading players of the In-Vitro Diagnostics and Cell Culture Medias market?

What changes are expected in the In-Vitro Diagnostics and Cell Culture Medias market in the next six years?

Which are the top product and leading applications of the In-Vitro Diagnostics and Cell Culture Medias market?

What are the leading market drivers and major risks factors for the In-Vitro Diagnostics and Cell Culture Medias market?

Which region/country leads and foresees highest growth in the next six years?

Purchase the Complete Global In-Vitro Diagnostics and Cell Culture Medias Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-59116

About Us:

DecisionDatabases.com is a global business research report provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map clients’ research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: sales@decisiondatabases.com Phone: +91-93077-28237 Website || Official Blog || Insights Analysis

[marketerefforts]

Centrifugation-free Sperm Separation Systems Market 2022 | Industry Size, Share, Demand And Growth Analysis Report Till 2028

The study on Centrifugation-free Sperm Separation Systems Market with its type and application sales analysis is very essential for all the decision-makers or strategists operating in this industry. The report is made by analysts with deep industry knowledge and experience. The global, regional, and country annual sales and revenue has been studied for the historical years and estimated for the current year. With the help of analytical tools, primary interviews, and data triangulation the report is enriched with quality data. The qualitative data on the upcoming industry trends with market triggers and risks are covered as a separate section in this comprehensive report.

As understood and analyzed in the global Centrifugation-free Sperm Separation Systems market report the growth CAGR in the year 2022 to 2028 is showing a promising inclination. The macro and microeconomic conditions are studied and forecast data is anticipated.

Click here to get a FREE Sample PDF Copy of the Centrifugation-free Sperm Separation Systems Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-59075

As per this report analysis, the Centrifugation-free Sperm Separation Systems market is expected to show a CAGR (revenue) of xx% between the forecast years and the global market size can cross USD XX million by the end of 2028, growing from USD XX million in the year 2022. This report specifically covers the global market share (sales as well as revenue) of key companies in the Centrifugation-free Sperm Separation Systems business, as mentioned in a separate Chapter 3.

Regionally, the Centrifugation-free Sperm Separation Systems market data is studied under the below-mentioned regions and countries – Americas covering (United States, Canada, Mexico, Brazil), APAC covering (China, Japan, Korea, Southeast Asia, India, Australia), Europe covering (Germany, France, UK, Italy, Russia, Spain), Middle East & Africa covering (Egypt, South Africa, Israel, Turkey, and other GCC Countries).

 This research study gives a comprehensive overview of market share and growth opportunities of the Centrifugation-free Sperm Separation Systems market as per type and application. The report also covers key manufacturers’ profiles with sales and gross margin data.

The key manufacturers covered in this report: Breakdown data in Chapter 3.

CooperSurgical, Inc.

Koek Biotechnology Bioengineering and Medical Services Industry & Trade, Inc.

Memphasys Ltd.

DxNow

SAR Healthline Pvt. Ltd.

Lotus Bio

Others

To inquire about report customization, feel free to reach out to our team of expert analysts @ https://www.decisiondatabases.com/contact/ask-questions-59075

This study considers the Centrifugation-free Sperm Separation Systems value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 11.7.

Migration-Sedimentation

Microfluidic Sperm Sorting

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 11.8.

Hospitals

IVF Centers

Others

The latest developments of the industry and the sales channel, manufacturing process along with the manufacturing cost study is covered in the report.

Key Questions Answered –

What will be the Centrifugation-free Sperm Separation Systems market CAGR and size between 2022-2028?

Who are the top/leading players of the Centrifugation-free Sperm Separation Systems market?

What changes are expected in the Centrifugation-free Sperm Separation Systems market in the next six years?

Which are the top product and leading applications of the Centrifugation-free Sperm Separation Systems market?

What are the leading market drivers and major risks factors for the Centrifugation-free Sperm Separation Systems market?

Which region/country leads and foresees highest growth in the next six years?

Purchase the Complete Global Centrifugation-free Sperm Separation Systems Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-59075

About Us:

DecisionDatabases.com is a global business research report provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map clients’ research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: sales@decisiondatabases.com Phone: +91-93077-28237 Website || Official Blog || Insights Analysis

[market-research-future]

Medical Tourism Market Key Companies Profile, Applications and Trends By 2027

Medical Tourism Market Scope

Market Research Future (MRFR) presumes that the medical tourism market will be worth USD 77.30 Billion by 2027. The medical tourism industry should capture close to 20.5% CAGR between 2020 and 2027 (analysis period).

Medical tourism offers a host of advantages such as latest medical technologies, cost-effectiveness, better healthcare, modern devices, better hospitality, innovative medicines, and personalized care. The medical tourism industry is touted to witness exponential growth in the years to come, in view of the dramatic rise in the number of surgical procedures that do not fall under insurance coverage, like gender reassignment operations, fertility treatment, dental reconstruction, and cosmetic surgery.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1975

Mounting unmet medical needs force people to opt for regions offering cost-efficient treatment options. Developments in hospital management also facilitate advances in the medical tourism field, while the appeal of comfortable as well as luxurious stays in medical facilities foster the market share as well. The blossoming geriatric patient base combined with the surging purchasing capacity of the middle-class populace will further uplift the position of the medical tourism industry in subsequent years.

Prominent hubs of medical tourism in Asia Pacific are Thailand, Singapore, Malaysia, Taiwan, India, South Korea, and Japan. Private hospitals as well as global investors see APAC as a highly lucrative business opportunity, leading to sizeable investments in equipment, infrastructure, services, and staff. Not to mention, the Middle East is home to several medical tourism powerhouses, with medical services in these countries gaining popularity owing to their low costs, non-existent queues, and English-speaking, skilled staff.

COVID-19 Impact on the Global Market

The COVID-19 outbreak has had a brutal effect on the medical tourism industry, given the strict lockdown rules, restricting the movement of goods as well as people.  In addition, the rising focus of the healthcare workers on managing the novel coronavirus instead of on other cases, the medical tourism market’s value dropped to a large extent. The shutdown of major airlines worldwide following the pandemic also cut down the number of medical tourists.

An overburdened healthcare sector all over the world, in line with shortage of doctors and other medical staff further affected the medical tourism industry. Sharp fall in pharmaceutical production has also been unfavorable for the global market.

Market Segmentation

The medical tourism market has been segregated into treatment type.

The treatment types discussed in the review report include fertility/IVF treatments, oncology/cancer treatments, orthopedic/spine treatments, neurology/neurosurgery treatment, dentistry treatments, cardiovascular/cardiology treatments, and cosmetic treatments.

Regional Insight

The Asia Pacific market for medical tourism is the highest gainer, thanks to the fast-developing countries with improving healthcare infrastructure. APAC forms the biggest share of 43.7% in the global industry, in response to the huge spending on technological advancements and development of cutting-edge medical machinery and equipment. South Korea is a thriving market for medical tourism in the region, with cosmetic procedures enjoying the highest demand among tourists.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/medical-tourism-market-1975

Thailand’s promising growth is also noteworthy, as the country offers medical tourists cheaper priced cosmetic treatment options. Escalating number of private hospitals, and advances in the healthcare infrastructure add to the APAC market’s worth. However, MRFR recognizes India as an attractive destination as well, with a hoard of medical tourists from developed economies coming here for ayurvedic massages and aromatherapeutic procedures. The availability of top-class, highly skilled medical expertise at reasonable prices in the country attracts patients from overseas. The most extensive demand is witnessed by high-end surgical procedures in India, including hip/knee replacement, cardiac bypass surgery, and more.

Significant Industry Firms

Some of the top firms in the medical tourism industry include Schoen-Kliniken, Samitivej PCL, CHRISTUS MUGUERZA, Anadolu Medical Center, Prince Court Medical Centre, Bangkok Hospital, Fortis Healthcare, Gleneagles Global Hospitals Group, Clemenceau Medical Center, Shouldice Hospital, Bumrungrad International Hospital, Asklepios Kliniken Verwaltungsgesellschaft mbH, to list a few.

Browse Related Reports at:

Global Nebulizers Market Research Report—Forecast till 2027

Global Menopause Treatment Market Research Report—Forecast till 2027

Global Whole Exome Sequencing Market Research Report—Forecast till 2027

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

[reportsanddata]

Fertility Enhancing Treatment Market  Size, Product Trends, Key Companies, Revenue Share Analysis, 2020–2027

A new research report titled global Fertility Enhancing Treatment market report published by Reports and Data provides a brief overview of the industry and gives an estimation of growth and revenue for the forecast period of 2021-2027. The report covers profiling and study of major manufacturers of the Fertility Enhancing Treatment market along with their sales, revenue, and market share. The report further analyzes market segments, size, trends, growth drivers, restraining factors, opportunities and challenges, cost overview, SWOT analysis, and Porter’s Five Forces Analysis. The report all includes industrial chain analysis, revenue growth, sales estimation, value chain analysis, capacity, regional market examination, and market forecast up to 2027. The report offers insightful information that will assist in gaining a market position and maximize on lucrative growth opportunities.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3515

The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.

Key companies operating in the market include:

Monash IVF, CooperSurgical Inc., Vitrolife AB, Merck & Co. Inc., Ferring Pharmaceuticals, Halotech DNA, IntegraMed America, Inc., and others.

The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3515

The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Fertility Enhancing Treatment market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.

On basis of product types and application offered by the Fertility Enhancing Treatment industry, the market is segmented into:

By Treatment (Revenue, USD Million; 2017-2027)

Ovarian Stimulation Fertility Drugs

Other fertility drugs for women

By Gender (Revenue, USD Million; 2017-2027)

Female

Male

By Distribution Channel (Revenue, USD Million; 2017-2027)

Hospital Pharmacy

Drug Stores

Retail Pharmacy

E-commerce

The regional analysis covers:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

US.

Canada

Mexico

Germany

UK.

Italy

France

BENELUX

Rest of Europe

China

India

Japan

South Korea

Rest of APAC

Brazil

Rest of LATAM

Saudi Arabia

A.E.

South Africa

Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/fertility-enhancing-treatment-market

Benefits of Fertility Enhancing Treatment Market Report:

Panoramic overview of the opportunities and risks in the Fertility Enhancing Treatment sector

Study of recent innovations and developments in the industry

Comprehensive study of the growth pattern of the Fertility Enhancing Treatment industry

In-depth assessment of the competitive landscape of the key players of the Fertility Enhancing Treatment industry

Analysis of the Fertility Enhancing Treatment market drivers, constraints, and opportunities

Assessment of technological developments and latest trends of the industry

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3515

Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.

Browse More Reports : Dental Implants Market  Companies

Apheresis Equipment Market  Research

[blueweave]

Asia Pacific Fertility Services Market Size, Share & Growth Projected to Grow at a CAGR of 15.2% during the Forecast Period | BlueWeave

Several factors are contributed to the growth of the Asia-Pacific fertility services market, including the increasing incidence of infertility rates in developing countries as well as medical advancements in the sector...

A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the Asia-Pacific fertility services market was worth USD 4.6 billion in the year 2020. According to the study, the market is estimated to grow at a CAGR of 15.2%, earning revenue of around USD 12.3 billion by the end of 2027. The Asia Pacific is experiencing a rising rate of infertility due to poor lifestyle habits. Thus, the growth of the Asia Pacific fertility services market can be attributed to increasing prevalence of infertility rates in people belonging to developing countries, along with various medical advancements being made in the domain of fertility treatment. Nevertheless, the high cost of fertility treatments may limit the growth of the market.

Flourishing Medical Tourism in Developing Countries Is Estimated to Boost the Market

Although fertility services involve expensive treatment and procedures, it still is cost-effective in the Asia Pacific as compared to receiving treatment in developed countries like the United States of America or the United Kingdom. This acts as a favorable factor for the growth of the Asia-Pacific fertility services market. For instance, the average cost of receiving an IVF treatment in the United States of America costs around USD 11,000 to USD 12,000 while in India it costs around USD 3,500 to USD 5,000. Several APAC countries have responded to opportunities offered by medical tourism, including India, Malaysia, Singapore and Thailand. These countries offer cross-border medical care for international tourists in an increasingly globally competitive environment. With flourishing medical tourism in countries like India, China, South Korea, the fertility services market is projected to boost significantly in the foreseeable future.

Increasing Average Age of Conceiving Is Boosting the Asia-Pacific Fertility Services Market

Health experts claim that the demand for fertility services is likely to increase in the upcoming years. One of the major factors driving the growth of the Asia-Pacific fertility services market is the increased age of parenthood. The global median age for bearing the first child has increased dramatically over the past few decades, especially in Asian countries such as Japan.Moreover, there has been an increase in the number of women working in the Asia Pacific, and this has resulted in a higher average age at which women have children. Furthermore, increasing divorce rates and second marriages are also influencing the growth of the Asia Pacific fertility services as people are choosing to start a second family at a relatively advanced age.

Asia-Pacific fertility services Market - By End-User

Based on end-users, the Asia-Pacific fertility services market is segmented into fertility clinics & surgical centers, hospitals, clinical research laboratories. The fertility clinics and surgical centers segment account for the largest market share. Individuals can avail of a wide spectrum of services at these centers including tests to analyze the root causes of infertility and treatment options to conceive and grow a family. These fertility and surgical centers adopt various diagnostics tests and advanced medical treatment and technologies to achieve conceptions and pregnancies. Other than the fertility and surgical centers, the hospitals and research laboratories segments are also growing at a substantial growth rate.

Request For Free Sample Report @ https://www.blueweaveconsulting.com/report/asia-pacific-fertility-services-market/report-sample

Asia-Pacific fertility services Market - Regional Insights

Geographically, the Asia-Pacific fertility services market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. Among these, India is leading the market. Japan and China are also emerging aspotential markets for fertility services with more than 600 fertility clinics and hospitals and around 460 licensed IVF clinics respectively operating. Japan is growing at a substantial growth rate in the fertility services market as people are starting to have children in the later years of their lives and are turning to medical support to conceive.

Impact of COVID-19 on Asia-Pacific fertility services Market

The Asia-Pacific fertility services market has been severely affected by the COVID-19-induced pandemic as the coronavirus brought a lot of challenges to the fertility services market in the region. Due to the lockdown imposed by the governments of different countries to prevent the spread of the virus, many fertility services were restricted.As a result, the demand for fertility services in Asia-Pacific regions witnessed a sharp decline. Furthermore, the economic slowdown, the decreasing per capita income of people, and lack of stability in individuals' lives caused several couples and individuals to delay their parenthood plans, affecting the market negatively.

Competitive Landscape

The leading market players in the Asia-Pacific fertility services market are Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center, Fertility First, MEHR IVF Clinic, Genea Oxford Fertility Limited, CHA Fertility Center, Maria Fertility Hospital, Superior A.R.T, Damai Service Hospital, Bourn Hall Fertility Center, Cloudnine Fertility, Shanghai United Family Hospital, Sanno Hospital, Oak Medical Group/Oak Clinic, Bahosi Fertility Centre, and other prominent players.

The market players offer a wide range of treatment and child-bearing options for childless couples and individuals with various medical conditions. They also invest and engage in R&D activities to expand and improve the chances of fertility options to gain a competitive edge in the market. Furthermore, the fertility-service providing facilities have also been adopting strategies such as partnerships, mergers, collaborations, etc., to develop their skills and services.

Don’t miss the business opportunity of the Asia-Pacific fertility services market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Asia-Pacific fertility services market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the Asia-Pacific fertility services market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Contact Us: BlueWeave Consulting & Research Pvt. Ltd US: +1 866 658 6826 | +1 425 320 4776 UK: +44 1865 60 0662 Email – info@blueweaveconsulting.com LinkedIn Page: https://www.linkedin.com/company/blueweaveconsulting/

[newsinsights]

The global mammalian transient protein expressions market is estimated to reach a valuation of approximately US$ 540 million in 2020

A recent market study published by Future Market Insights on the Mammalian Transient Protein Expression market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics and Covid-19 crisis impact analysis. After conducting a thorough research on the historical as well as current growth parameters of the market, the growth prospects of the market are obtained with maximum precision.

Mammalian Transient Protein Expression Market: Segmentation

The Mammalian Transient Protein Expression market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

Instruments

Expression Vector

Reagents & Consumables

Cell Lines

Chinese Hamster Ovary Cells

Human Embryonic Kidney Cells

Others

Application

Bio Production

Functional Cell Based Assays

Academic Research

Others

Antibody Production

Therapeutic Protein Production

End User

Contract Research Organization

Biopharmaceutical Companies

Academic & Research Institutes

Region

North America (U.S., Canada)

Latin America (Brazil, Mexico, Argentina, and Rest of Latin America)

Europe (Germany, Switzerland, France, UK, Rest of Europe)

East Asia (China, Japan, South Korea)

South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)

Oceania (Australia and New Zealand)

Middle East & Africa (GCC Countries, Turkey, South Africa, Rest of MEA)

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12807

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint.

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the Mammalian Transient Protein Expression market, which includes a summary of key findings and statistics of the market. It also includes supply-side and demand-side trends pertaining to the Mammalian Transient Protein Expression market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the Mammalian Transient Protein Expression market in this chapter, which will help them understand the basic information about the Mammalian Transient Protein Expression market. Along with this, comprehensive information pertaining to Mammalian Transient Protein Expression and their features are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the Mammalian Transient Protein Expression market report.    

Chapter 03 – Key Market Trends

Mammalian Transient Protein Expression market report provides the key market trends that are expected to significantly impact market growth during the forecast period. Detailed industry trends are provided in this section.

Chapter 04 – Key Success Factors

This section includes detailed analysis of Mammalian Transient Protein Expression products usage analysis, promotional strategies, pipeline assessment and regulatory and reimbursement scenario

Chapter 05 – Market Background

This chapter includes drivers and restraints of the Mammalian Transient Protein Expression market. This section also includes macroeconomic factors, and various opportunities of the Mammalian Transient Protein Expression market.

Chapter 06 – COVID-19 Crisis analysis

This section explains COVID-19 impact on the market, forecast factors, and economic impact.

Chapter 07 – Cost Analysis

This section explains production cost of mammalian transient protein expression using various cell lines.

Chapter 08 – Global Mammalian Transient Protein Expression Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

This section explains the global market value analysis and forecast for the Mammalian Transient Protein Expression market during the forecast period. This chapter includes a detailed analysis of the historical Mammalian Transient Protein Expression market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030)

Any Queries, Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-12807

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies

Detailed insights of market segments and sub-segments for historical as well as forecast period

A competitive analysis of prominent players and emerging players in the Radiometric Detectors market

Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Visit More Healthcare Reports:

U.S. Compounding Pharmacies Market: Compounding Pharmacies Market: U.S. Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028

Vision Screeners Market:  Vision Screeners Market: R&D Innovations to Overcome Pediatric Vision Screening Challenges Trending: Global Industry Analysis 2014 - 2018 and Opportunity Assessment 2019 - 2029

Donor Egg IVF (In-Vitro Fertilization) Market: Donor Egg IVF (In-Vitro Fertilization) Market: Government Funding & Reimbursement Policies to Play Instrumental Role: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 -2028

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

[marketreports-world]

Global Preimplantation Genetic Testing Market - Forecast Till 2027

Global Preimplantation Genetic Testing Market Research Report: Information by Procedure (Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening), Type (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, LA Typing and others), Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late-Onset Genetic Disorders, Inherited Genetic Disease and others), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Product and Service (Reagents and Consumables, Instruments, Software and Services) - Global Forecast till 2027

Market Highlights

It is estimated that the global preimplantation genetic testing market is expected to register a CAGR of 10.2% during the forecast period of 2019 to 2025, with a market value of USD 375.8 million in 2018.

Preimplantation genetic testing is the testing at the pre-implantation stage for detection of genetic defects in embryos or oocytes. Preimplantation genetic testing has occurred more frequently in recent years in North America and Europe, due to the advancement in genetic technology.

The decreasing fertility rates worldwide enhance the acceptance of the preimplantation genetic testing to avoid further complications of chromosomal abnormalities with advancing maternal age. This leads to the growth of the preimplantation genetic testing market during the forecast period. According to the Vital Statistics Rapid Release, the total fertility rate for the US in 2017 was 1,764.5 births per 1,000 women, and in 2016 it was 1,820.5,  which is 3% less, this shows the reduction in the rate of fertility.

An increasing number of fertility clinics worldwide, new development technological advancements in the field of genetic analysis and high threat of chromosomal abnormalities with advancing maternal age are the other driving factors for global preimplantation genetic testing market

Segmentation

The global preimplantation genetic testing market is segmented based on procedure, type, application, technology, product and service, end user, and region.

The global market for preimplantation genetic testing, by procedure, is segmented into preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS). Hundred different genetic conditions can be tested with Preimplantation Genetic Diagnosis (PGD) which enables the couple to have a baby with no genetic defect thus the segment is expected to hold the largest market share owing to rising awareness population and healthcare experts. Preimplantation Genetic Screening (PGS) segment is also anticipated to grow profitably to increase healthy pregnancy.

By type, embryo testing segment is expected to show favorable growth as the threat of chromosomal abnormalities increases. By product and service, the reagents and consumables segment anticipated to hold the largest market share as there is continuous declination infertility of female due to increasing usage of reagents for the diagnosis. By technology, the next-generation sequencing segment, and comparative genomic hybridization also expected to hold large share as its cost is reduced and its capability to detect mosaicism. The market by end user has been segmented into maternity centers & fertility clinics

hospitals, diagnostic labs and research laboratories & academic institutes.  Based on region, the global preimplantation genetic testing market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8121

Key Players

Some of the major players in the global preimplantation genetic testing market are Natera, Inc.CooperSurgical, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., IGENOMIX, Reprogenetics, LLC, Genea Limited, PerkinElmer, Inc., Genesis Genetics Ltd., Quest Diagnostics Incorporated, Thermo FisherScientific, Inc, Bioarrayn Genetics, Laboratory Corporation of America Holdings, California Pacific Medical Center and Reproductive Health Science Ltd

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The global preimplantation genetic testing market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European global preimplantation genetic testing market has been sub-divided Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The global preimplantation genetic testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The IPF treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

Table Of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunities

5.4 Pricing Analysis

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/preimplantation-genetic-testing-market-8121

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Related Report:

Preimplantation Genetic Testing Market Analysis - Forecast Report Till 2023

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com